(Q36492380)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

review article

1 reference

title

Toward biomarkers in multiple sclerosis: new advances (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Paolo Rovero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Mario Chelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Anna Maria Papini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Paolo Rovero

2

1 reference

14 August 2017

Mario Chelli

3

1 reference

14 August 2017

Anna Maria Papini

4

1 reference

14 August 2017

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

28 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

781-794

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Multiple Sclerosis Pathology: Evolution of Pathogenetic Concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Development of biomarkers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Consensus recommendations of the Italian Association for Neuroimmunology for immunochemical cerebrospinal fluid examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

T-cell-mediated autoimmunity: novel techniques to characterize autoreactive T-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

B cells and antibodies in CNS demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

CD8+ T cell-mediated HLA-A*0201-restricted cytotoxicity to transaldolase peptide 168-176 in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Maintenance of B lymphocyte-related clones in the cerebrospinal fluid of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Antibodies against viruses and structural brain components in oligoclonal IgG obtained from multiple sclerosis brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Identification of autoantibodies associated with myelin damage in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Lipid microarrays identify key mediators of autoimmune brain inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Millennium Award. Proteomics for the development of DNA tolerizing vaccines to treat autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Genomic and proteomic analysis of multiple sclerosis. Opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Improved resolution of human cerebrospinal fluid proteins on two-dimensional gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Proteomic analysis of multiple sclerosis cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Towards two-dimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A distinctive molecular signature of multiple sclerosis derived from MALDI-TOF/MS and serum proteomic pattern analysis: detection of three biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Towards data management of the HUPO Human Brain Proteome Project pilot phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Autoantibody profiling for the study and treatment of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

High-throughput methods for measuring autoantibodies in systemic lupus erythematosus and other autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Peptidylarginine deiminase activity in postmortem white matter of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Citrullination of central nervous system proteins during the development of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Post-translational protein modifications in antigen recognition and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Human PAD4 regulates histone arginine methylation levels via demethylimination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Histone deimination antagonizes arginine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

PAD: the smoking gun behind arginine methylation signaling?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The effects of deimination of myelin basic protein on structures formed by its interaction with phosphoinositide-containing lipid monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Citrullinated myelin basic protein induces experimental autoimmune encephalomyelitis in Lewis rats through a diverse T cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Paclitaxel (Taxol) attenuates clinical disease in a spontaneously demyelinating transgenic mouse and induces remyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Inhibition of experimental allergic encephalomyelitis in the Lewis rat by paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Antibody responses in chronic relapsing experimental allergic encephalomyelitis: correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The pathogenesis of primary progressive multiple sclerosis: antibody-mediated attack and no repair?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Neuromyelitis optica: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Presentation, management and follow-up of Schilder's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Biological markers in CSF and blood for axonal degeneration in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A structural scaffolding of intermediate filaments in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Core biological marker candidates of Alzheimer's disease - perspectives for diagnosis, prediction of outcome and reflection of biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Tau protein level in cerebrospinal fluid is increased in patients with early multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Decreased levels of the brain specific 24S-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The telltale scan: APOE epsilon4 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Demyelination and axonal damage in a non-human primate model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The 14-3-3 protein epsilon isoform expressed in reactive astrocytes in demyelinating lesions of multiple sclerosis binds to vimentin and glial fibrillary acidic protein in cultured human astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A controlled trial of natalizumab for relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

T cell vaccination in multiple sclerosis: results of a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Serum and cerebrospinal fluid antibodies to Nogo-A in patients with multiple sclerosis and acute neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Simple test for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions?tautwopathy distinct from degenerative tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.5.781

21 January 2018

Identifiers

DOI

10.1586/14737175.6.5.781

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16734525%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference